Skip to navigation Skip to sub-navigation Skip to content

People

Victoria Calzada

Victoria Calzada

Postdoctoral Fellow

Phone: (573) 884-5159
calzadav@missouri.edu
415 Bond LIfe Sciences Center

News about Victoria Calzada

2020

Sgc8-c Aptamer as a Potential Theranostic Agent for Hemato-Oncological Malignancies. Sicco E, Baez J, Ibarra M, Fernández M, Cabral P, Moreno M, Cerecetto H, Calzada V. Cancer Biotherapy and Radiopharmaceuticals; 35(4):262-270.

Date published: May 1, 2020
Featured in this article: Victoria Calzada.

Go to article...

2019

Aptamers in diagnostic and molecular imaging applications. Calzada V. Advances in Biochemical Engineering/Biotechnology; 174:141-160.

Date published: December 18, 2019
Featured in this article: Victoria Calzada.

Go to article...

2018

Derivatizations of Sgc8-c aptamer to prepare metallic radiopharmaceuticals as imaging diagnostic agents: Syntheses, isolations, and physicochemical characterizations. Sicco E, Báez J, Margenat J, García F, Ibarra M, Cabral P, Moreno M, Cerecetto H, Calzada V. Chemical Biology and Drug Design; 91(3):747-755.

Date published: March 1, 2018
Featured in this article: Victoria Calzada.

Go to article...

2017

177Lu-DOTA-bevacizumab: Radioimmunotherapy agent for melanoma. Camacho X, Calzada V, Fernández M, Alonso O, Chammas R, Riva E, Gambini JP, Cabral P. Current Radiopharmaceuticals; 10(1):21-28.

Date published: March 7, 2017
Featured in this article: Victoria Calzada.

Go to article...

Development of new PTK7-targeting aptamer-fluorescent and -radiolabelled probes for evaluation as molecular imaging agents: Lymphoma and melanoma in vivo proof of concept. Calzada V, Moreno M, Newton J, González J, Fernández M, Gambini JP, Ibarra M, Chabalgoity A, Deutscher S, Quinn T, Cabral P, Cerecetto H. Bioorganic and Medicinal Chemistry; 25(3):1163-1171.

Date published: February 1, 2017
Featured in this article: Victoria Calzada, Thomas Quinn.

Go to article...

2016

Fab(Nimotuzumab)-HYNIC-99mTc: Antibody fragmentation for molecular imaging agents. Calzada V, García MF, Alonso-Martínez LM, Camacho X, Goicochea E, Fernández M, Castillo AX, Díaz-Miqueli A, Iznaga-Escobar N, Montaña RL, Alonso O, Gambini JP, Cabral P. Anti-Cancer Agents in Medicinal Chemistry; 16(9):1184-1189.

Date published: October 1, 2016
Featured in this article: Victoria Calzada.

Go to article...

2014

Microwave-assisted synthesis of HYNIC protected analogue for 99mTc labeled antibody. García MF, Calzada V, Camacho X, Goicochea E, Gambini JP, Quinn TP, Porcal W, Cabral P. Current Radiopharmaceuticals; 7(2):84-90.

Date published: October 1, 2014
Featured in this article: Victoria Calzada, Thomas Quinn.

Go to article...

Development of 90Y-DOTA-nimotuzumab Fab fragment for radioimmunotherapy. Alonso Martínez LM, Xiques Castillo A, Calzada Falcón VN, Pérez-Malo Cruz M, Leyva Montaña R, Zamora Barrabí M, Hernández González I, León Pérez M, Arbesú Valdivia A. Journal of Radioanalytical and Nuclear Chemistry; 302(1):49-56.

Date published: October 1, 2014
Featured in this article: Victoria Calzada.

Go to article...

Cursos masivos: Ampliando expectativas [Massive courses: Increasing expectations]. Calzada V, Lecot N, García MF, Cabrera M, Camacho X, Tassano M, Castelli R, Czerwonogora A, Goicochea E, González M, Cabral P, Cerecetto H. Educacion Quimica; 25(E1):254-257.

Date published: May 15, 2014
Featured in this article: Victoria Calzada.

Go to article...

99mTc-labeled Bevacizumab via HYNIC for imaging of melanoma. Camacho X, García MF, Calzada V, Fernández M, Alonso O, Gambini JP, de Aguiar RB, Machado CML, Chammas R, Porcal W, Cabral P. Journal of Analytical Oncology; 3(1):53-64.

Date published: February 18, 2014
Featured in this article: Victoria Calzada.

Go to article...

2013

Synthesis and evaluation of 99mTc chelate-conjugated Bevacizumab. Camacho X, García MF, Calzada V, Fernández M, Porcal W, Alonso O, Gambini JP, Cabral P. Current Radiopharmaceuticals; 6(1):12-19.

Date published: March 19, 2013
Featured in this article: Victoria Calzada.

Go to article...

[99mTc(CO)3]-radiolabeled bevacizumab: In vitro and in vivo evaluation in a melanoma model. Camacho X, García MF, Calzada V, Fernández M, Chabalgoity JA, Moreno M, Barbosa De Aguiar R, Alonso O, Gambini JP, Chammas R, Cabral P. Oncology (Switzerland); 84(4):200-209.

Date published: March 1, 2013
Featured in this article: Victoria Calzada.

Go to article...

2012

A potencial theranostic agent for EGF-R expression tumors: 177Lu- DOTA-nimotuzumab. Calzada V, Zhang X, Fernández M, Díaz-Miqueli A, Iznaga-Escobar N, Deutscher SL, Balter H, Quinn TP, Cabral P. Current Radiopharmaceuticals; 5(4):318-324.

Date published: September 18, 2012
Featured in this article: Victoria Calzada, Thomas Quinn.

Go to article...

Synthesis of 99mTc-nimotuzumab with tricarbonyl ion: In vitro and in vivo studies. García MF, Camacho X, Calzada V, Fernández M, Porcal W, Alonso O, Gambini JP, Cabral P. Current Radiopharmaceuticals; 5(1):59-64.

Date published: January 1, 2012
Featured in this article: Victoria Calzada.

Go to article...